401(k) · DOL Form 5500 · 2023

Crispr Therapeutics, Inc. 401(k) Plan

Data updated 2026-08-25

$54M
Total assets Below avg plan size
449
Participants Below avg headcount
86th
Percentile by assets National rank
$119,862
Avg per participant Near avg balance/head
PlainRetire home → About this data RSS: change history

Official DOL plan name: Crispr Therapeutics 401(k) Retirement Plan · Sponsored by Crispr Therapeutics, Inc. · Massachusetts · Professional & Technical Services

$54M in assets, 449 participants

Crispr Therapeutics, Inc.'s Crispr Therapeutics 401(k) Retirement Plan reported $54M in total assets and 449 participants in its 2023 DOL Form 5500 filing, ranking in the 86th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • #17,742 in Professional & Technical Services (20,321 peers)

Where Crispr Therapeutics 401(k) Retirement Plan sits by assets

Crispr Therapeutics 401(k) Retirement Plan sits in the top quartile of all filed plans by assets, $54M for 449 participants (~$119,862/participant), up 43.0% in 2023.

#17,742
in Professional & Technical Services (20,321 peers)
+43.0%
assets growth YoY
0.5×
vs typical plan assets (national mean)

Crispr Therapeutics 401(k) Retirement Plan's outsized position by total assets

Crispr Therapeutics 401(k) Retirement Plan vs every filed plan by assets

End-of-year total assets · plan year 2023 · DOL Form 5500

$53,817,882 Top 14% higher than 86% of 127,068 filed plans

This plan $0 $2,050,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2023

Crispr Therapeutics 401(k) Retirement Plan among mid-size filed plans by headcount

Plan-year 2023 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Crispr Therapeutics 401(k) Retirement Plan sits mid-pack in the medium band (449 participants).

What changed between DOL Form 5500 filings

plan year 2022 → plan year 2023

  • Crispr Therapeutics 401(k) Retirement Plan reported net income rose from $2M in the plan year 2022 filing to $16M in the plan year 2023 filing.
  • Crispr Therapeutics 401(k) Retirement Plan end-of-year assets rose from $38M in the plan year 2022 filing to $54M in the plan year 2023 filing.
  • Crispr Therapeutics 401(k) Retirement Plan reported participants fell from 466 in the plan year 2022 filing to 449 in the plan year 2023 filing.

See the national 2022→2023 release diff →

Published 5500 schedule card

Filing strip 473173478 · Crispr Therapeutics, Inc. PY 2023 · 401(k)

Crispr Therapeutics 401(k) Retirement Plan · $54M · 449 · 86th

  • EBSA $54M
  • EBSA 449
  • EBSA 86th
  • EBSA 401(k)
  • EBSA near Janus Research Group 401(k) Plan
  • EBSA ind #17742

Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Professional & Technical Services retirement plans → · Plans in Massachusetts →

Crispr Therapeutics 401(k) Retirement Plan in the asset neighbourhood

Crispr Therapeutics 401(k) Retirement PlanCrispr Therapeutics 401(k) R…$54MJanus Research Group 401(k) PlanJanus Research Group 401(k) …$54MSan Diego Padres Baseball Club 401(k) Savings PlanSan Diego Padres Baseball Cl…$54MTumi, Inc. Profit Sharing/401(k) PlanTumi, Inc. Profit Sharing/40…$54MStar Financial Group, Inc. 401(k) Savings PlanStar Financial Group, Inc. 4…$54M
End-of-year total assets ($M) among Crispr Therapeutics 401(k) Retirement Plan and nearest nationwide 401(k) peers. Source: DOL Form 5500 plan year 2023.

Scale-class filing particulars (2023)

Total Assets (Beginning of Year)$38M
Net Assets (End of Year)$54M
Net Income$16M
Employer EIN473173478
Plan Effective Date2016-11-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Crispr Therapeutics, Inc.)

Sponsor-wide plan assets over time

All Crispr Therapeutics, Inc. plans reported in each filing year

Latest sponsor-wide plan assets
$67M 77.1988071667229% vs 2022
2024 filing year
$30M$40M$50M$60M$70M 202220232024 $37.6M $66.7M ▲ +77.2%
Year Plans Participants Total Assets
2022 1 466 $38M
2023 1 449 $54M
2024 1 399 $67M

Nearby 401(k) Plans in Massachusetts

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Crispr Therapeutics 401(k) Retirement Plan vs. nearby 401(k) plans in Massachusetts, assets vs. participants Scatter plot of 6 data points. -20000020000400006000080000 -10010203040 Total assets ($B) Participants Crispr Therapeutics 401(k) Retirement Plan, Total assets ($B): 0.053817882 · Participants: 449Crispr Therapeutics 401(k) Retirement PlanFidelity Retirement Savings Plan, Total assets ($B): 28.649852331 · Participants: 62289Fidelity Retirement Savings PlanLiberty Mutual 401(k) Plan, Total assets ($B): 10.556596852 · Participants: 37052Liberty Mutual 401(k) PlanMassachusetts Institute of Technology Supplemental 401(k) Plan, Total assets ($B): 6.829912863 · Participants: 14094Massachusetts Institute of Technology Supplemental 401(k) PlanBoston Scientific Corporation 401(k) Retirement Savings Plan, Total assets ($B): 5.786107181 · Participants: 19881Boston Scientific Corporation 401(k) Retirement Savings PlanPhilips North America 401(k) Plan, Total assets ($B): 5.779286156 · Participants: 19120Philips North America 401(k) Plan
Crispr Therapeutics 401(k) Retirement Plan vs. nearby 401(k) plans in Massachusetts, assets vs. participants
Compare Crispr Therapeutics 401(k) Retirement Plan side-by-side with 3 peers →

Crispr Therapeutics 401(k) Retirement Plan's out-of-state 401(k) peers by assets and headcount

Outside Massachusetts, the nearest 401(k) by assets is Janus Research Group 401(k) Plan in GA ($54M); by covered participants it is The Mortgage Firm, Inc. 401(k) Plan in FL (449 participants). Same-state nearby plans are listed separately above.

Similar participant headcount

Nearest other-state filings by covered participants (449 participants); asset peers above are excluded.

DOL Form 5500 plan year 2023. Asset totals can differ widely at the same headcount; neither axis is a quality rating.

Frequently Asked Questions

How did Crispr Therapeutics 401(k) Retirement Plan assets move in 2023? ▼
Crispr Therapeutics 401(k) Retirement Plan surged - up 43.0% during 2023, from $38M to $54M. Reported net income was $16M.
How have Crispr Therapeutics, Inc. plan assets changed over time? ▼
Across 3 plan years on file (2022-2024), Crispr Therapeutics, Inc.'s sponsor-wide assets grew 77.2%, from $38M to $67M.
Where does Crispr Therapeutics 401(k) Retirement Plan rank by assets among Form 5500 filers? ▼
Crispr Therapeutics 401(k) Retirement Plan ranks in the 86th percentile by end-of-year assets among 127,072 plans that reported assets for plan year 2023 (in the top quartile of all filed plans by assets).
Which 401(k) plans are similar in size to Crispr Therapeutics 401(k) Retirement Plan? ▼
Among 401(k) plans in other states, the closest by assets is Janus Research Group 401(k) Plan in GA ($54M, 486 participants).
Which 401(k) plans cover a similar participant headcount to Crispr Therapeutics 401(k) Retirement Plan? ▼
Among 401(k) plans in other states, the closest by covered participants is The Mortgage Firm, Inc. 401(k) Plan in FL (449 participants, $27M in assets).

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 473173478.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from U.S. Department of Labor Form 5500 filings (EBSA). See our methodology for details.